Fig. 2From: Determinants of associated events following AZD1222 (Covishield) vaccination in a high-risk population in NepalSeverity of symptoms after the first and second doses of Covishield (percentageā=ānumber of individual symptoms per total respondents in each round of vaccination). AEFIs after the second dose tended to be milder than after the first dose. In the truncated data representing the 516 participants who participated in both rounds, reported AEFIs were less severe during the second round (Ļ2ā=ā102.7, dfā=ā12, pā<ā0.001) vis-Ć -vis first roundBack to article page